CY1126138T1 - Χρηση ενος αναστολεα ακετυλοχολινεστερασης και ιδαλοπιρδινης για την μειωση των πτωσεων ασθενων που πασχουν απο τη νοσο toy parkinson - Google Patents

Χρηση ενος αναστολεα ακετυλοχολινεστερασης και ιδαλοπιρδινης για την μειωση των πτωσεων ασθενων που πασχουν απο τη νοσο toy parkinson

Info

Publication number
CY1126138T1
CY1126138T1 CY20231100395T CY231100395T CY1126138T1 CY 1126138 T1 CY1126138 T1 CY 1126138T1 CY 20231100395 T CY20231100395 T CY 20231100395T CY 231100395 T CY231100395 T CY 231100395T CY 1126138 T1 CY1126138 T1 CY 1126138T1
Authority
CY
Cyprus
Prior art keywords
disease
patients suffering
idalopirdine
parkinson
acetylcholinesterase inhibitor
Prior art date
Application number
CY20231100395T
Other languages
English (en)
Inventor
Inge E M DE JONG
Aaron Kucinski
Martin Sarter
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of CY1126138T1 publication Critical patent/CY1126138T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με τη χρήση ενός αναστολέα ακετυλοχολινεστεράσης και ιδαλοπιρδίνης για την μείωση των πτώσεων των ασθενών που πάσχουν από κάποια νόσο του ΚΝΣ, και συγκεκριμένα ασθενών που πάσχουν από τη νόσο του Parkinson, οπότε και επηρεάζεται αρνητικά η ισορροπία, η βάδιση ή η κίνηση.
CY20231100395T 2016-04-26 2023-08-04 Χρηση ενος αναστολεα ακετυλοχολινεστερασης και ιδαλοπιρδινης για την μειωση των πτωσεων ασθενων που πασχουν απο τη νοσο toy parkinson CY1126138T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201600248 2016-04-26
PCT/EP2017/059739 WO2017186686A1 (en) 2016-04-26 2017-04-25 Use of an acetylcholinesterase inhibitor and idalopirdine for reducing falls in parkinson's disease patients

Publications (1)

Publication Number Publication Date
CY1126138T1 true CY1126138T1 (el) 2023-11-15

Family

ID=58632402

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20231100395T CY1126138T1 (el) 2016-04-26 2023-08-04 Χρηση ενος αναστολεα ακετυλοχολινεστερασης και ιδαλοπιρδινης για την μειωση των πτωσεων ασθενων που πασχουν απο τη νοσο toy parkinson

Country Status (27)

Country Link
US (1) US10383849B2 (el)
EP (1) EP3448430B1 (el)
JP (1) JP6992004B2 (el)
KR (1) KR102473545B1 (el)
CN (1) CN109069650A (el)
AU (1) AU2017256623B2 (el)
BR (1) BR112017026928B1 (el)
CA (1) CA3020557C (el)
CL (1) CL2018003013A1 (el)
CY (1) CY1126138T1 (el)
DK (1) DK3448430T3 (el)
ES (1) ES2949288T3 (el)
FI (1) FI3448430T3 (el)
HR (1) HRP20230693T8 (el)
HU (1) HUE062626T2 (el)
IL (1) IL262546B (el)
LT (1) LT3448430T (el)
MX (1) MX2018013031A (el)
PL (1) PL3448430T3 (el)
PT (1) PT3448430T (el)
RS (1) RS64307B1 (el)
RU (1) RU2742173C2 (el)
SG (1) SG11201809297UA (el)
SI (1) SI3448430T1 (el)
TW (1) TW201806621A (el)
WO (1) WO2017186686A1 (el)
ZA (1) ZA201806864B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201909895UA (en) * 2017-05-24 2019-11-28 H Lundbeck As Combination of a 5-ht6 receptor antagonist and an acetylcholinesterase inhibitor for use in the treatment of alzheimer's disease in a patient subpopulation carrying apoe4 alleles
JP2021515801A (ja) * 2017-12-22 2021-06-24 ニューロセア,エルエルシー 神経変性疾患における転倒および転倒頻度に関連する処置のための組成物および方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818914D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
DK1379239T3 (da) * 2001-03-29 2008-01-07 Lilly Co Eli N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
WO2006107860A2 (en) * 2005-04-04 2006-10-12 Eisai Co., Ltd. Dihydropyridine compounds and compositions for headaches
PE20071143A1 (es) * 2006-01-13 2008-01-20 Wyeth Corp Composicion farmaceutica que comprende un inhibidor de acetilcolinesterasa y un antagonista 5-hidroxitriptamina-6
US20100120747A1 (en) * 2006-06-23 2010-05-13 Laboratorios Del Dr. Esteve, S.A. Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
US9084742B2 (en) * 2007-12-12 2015-07-21 Axovant Sciences Ltd. Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
RU2393158C1 (ru) * 2008-10-06 2010-06-27 Андрей Александрович Иващенко ЗАМЕЩЕННЫЕ 3-АРИЛСУЛЬФОНИЛ-ПИРАЗОЛО[1,5-а]ПИРИМИДИНЫ, АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
JO3459B1 (ar) 2012-09-09 2020-07-05 H Lundbeck As تركيبات صيدلانية لعلاج مرض الزهايمر

Also Published As

Publication number Publication date
HRP20230693T1 (hr) 2023-10-13
JP2019519480A (ja) 2019-07-11
SI3448430T1 (sl) 2023-08-31
DK3448430T3 (da) 2023-07-03
LT3448430T (lt) 2023-07-25
US10383849B2 (en) 2019-08-20
BR112017026928A2 (pt) 2018-08-14
TW201806621A (zh) 2018-03-01
HUE062626T2 (hu) 2023-11-28
HRP20230693T8 (hr) 2023-11-10
CL2018003013A1 (es) 2018-12-14
RU2742173C2 (ru) 2021-02-02
RU2018135846A3 (el) 2020-09-30
JP6992004B2 (ja) 2022-02-03
ZA201806864B (en) 2020-01-29
CA3020557A1 (en) 2017-11-02
US20170304267A1 (en) 2017-10-26
WO2017186686A1 (en) 2017-11-02
PT3448430T (pt) 2023-07-11
RU2018135846A (ru) 2020-05-26
BR112017026928B1 (pt) 2023-04-11
FI3448430T3 (fi) 2023-06-20
PL3448430T3 (pl) 2023-08-21
AU2017256623B2 (en) 2022-07-21
KR20180133869A (ko) 2018-12-17
AU2017256623A1 (en) 2018-11-01
IL262546B (en) 2022-05-01
EP3448430B1 (en) 2023-06-07
RS64307B1 (sr) 2023-07-31
MX2018013031A (es) 2019-01-17
IL262546A (en) 2018-12-31
CN109069650A (zh) 2018-12-21
SG11201809297UA (en) 2018-11-29
CA3020557C (en) 2024-05-21
KR102473545B1 (ko) 2022-12-01
EP3448430A1 (en) 2019-03-06
ES2949288T3 (es) 2023-09-27

Similar Documents

Publication Publication Date Title
CY1121473T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1122184T1 (el) Συνθεσεις περιλαμβανουσες βακτηριακα στελεχη
CY1123381T1 (el) Συνθεσεις που περιεχουν βακτηριακα στελεχη
CY1122306T1 (el) Συνθεσεις που περιλαμβανουν bakthpiaka στελεχη
CY1126138T1 (el) Χρηση ενος αναστολεα ακετυλοχολινεστερασης και ιδαλοπιρδινης για την μειωση των πτωσεων ασθενων που πασχουν απο τη νοσο toy parkinson
CY1124084T1 (el) Αμιδο-υποκατεστημενα παραγωγα πυριδινυλοτριαζολης και χρησεις αυτων
MA53356A (fr) Formulations sous-cutanées d'anticorps anti-cd38 et leurs utilisations
CY1122148T1 (el) Συνθεσεις που περιεχουν βακτηριακα στελεχη
CY1120941T1 (el) Παραγωγα φαινυλοτριαζολιου υποκατεστημενα με υδροξυαλκυλιο και χρησεις αυτων
MD3549592T2 (ro) Compoziții care conţin tulpini bacteriene
CY1120452T1 (el) Παραγωγο αμιδιου πυραζολης
CY1122265T1 (el) Αντισωματα εναντι ταυ και χρησεις αυτων
PH12015502788A1 (en) Antibody formulations and methods
CY1125047T1 (el) Διεργασιες για την παρασκευη ενωσεων τυπου οξαθειαζινης
JOP20210305A1 (ar) صيغ إيماتينيب وتصنيعها واستخداماتها
EA201990400A1 (ru) Соединения и композиции и их применение
DK3720433T3 (da) Bis-cholin-tetrathiomolybdat til behandling af wilsons sygdom
EA201891644A1 (ru) Антибактериальные соединения и их применение
CY1120700T1 (el) Ενωσεις τριαμινοπυριμιδινης χρησιμες για προληψη ή αγωγη ελονοσιας
CY1122375T1 (el) Συμπυκνωμενα με τετραϋδροφουρανιο αμινοϋδροθειαζινικα αναλογα τα οποια ειναι χρησιμα στη θεραπεια της νοσου toy alzheimer
CY1124851T1 (el) Νεες ενωσεις
EA202090734A1 (ru) Применение диамина для увеличения механической прочности волос и средство для ухода за волосами, его содержащее
UA39181S (uk) Підвісок «черевичок мальвіни»
UA39178S (uk) Підвісок «черевичок рапунцель»
UA39180S (uk) Підвісок «черевичок дюймовочки»